Recursion Pharmaceuticals
Jul 16, 2019
Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod
AI-powered drug-maker Recursion Pharmaceuticals secures USD 121 M to accelerate its clinical programs Recursion Pharmaceuticals, a next-gen biopharma company, has raised USD 121 Million in Series C financing. The Series C round was led by Baillie Gifford's flagship investment trust, Scottish Mortgage Investment...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
